Centro de Oncologia Mackenzie

Curitiba, Paraná 80440-220

0 studies enrolling now · 2 studies all time

What they study most

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Solid Tumors

Studies at this site

• A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression — Stopped early
• Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression — Completed